Feature Channels: Vision

Filters close
Newswise: “Eggsplosions” and eyes don’t mix
Released: 31-Jul-2023 5:00 PM EDT
“Eggsplosions” and eyes don’t mix
Michigan Medicine - University of Michigan

Microwaving hard-boiled eggs is one of the latest TikTok trends that can harm your eyes

Newswise: Cedars-Sinai July Research Highlights
Released: 28-Jul-2023 11:50 AM EDT
Cedars-Sinai July Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Released: 28-Jul-2023 10:50 AM EDT
Retina cell breakthrough could help treat blindness
Anglia Ruskin University

Scientists have found a way to use nanotechnology to create a 3D ‘scaffold’ to grow cells from the retina –paving the way for potential new ways of treating a common cause of blindness.

Released: 28-Jul-2023 10:45 AM EDT
Enhanced light sensitivity may contribute to Alzheimer's 'sundowning,' disease progression
University of Virginia Health System

New Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning” – the worsening of symptoms late in the day – and spur sleep disruptions thought to contribute to the disease’s progression.

27-Jul-2023 2:55 PM EDT
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2024 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Research to Prevent Blindness

Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.

Newswise: New app developed at NYU Tandon School of Engineering promises to make navigating subway stations easier for people with blindness and low vision
Released: 27-Jul-2023 9:00 AM EDT
New app developed at NYU Tandon School of Engineering promises to make navigating subway stations easier for people with blindness and low vision
NYU Tandon School of Engineering

Designed by researchers at NYU Tandon School of Engineering and NYU Grossman School of Medicine, Commute Booster routes public-transportation users through the “middle mile” – the part of a journey inside subway stations or other similar transit hubs – in addition to the “first” and “last” miles that bring travelers to and from those hubs.

   
Released: 26-Jul-2023 12:05 PM EDT
American Academy of Ophthalmology’s Research Journals Ranked Highest in the Field
American Academy of Ophthalmology (AAO)

The recently released 2022 impact factor scores reveal that the research journals Ophthalmology, Ophthalmology Retina and Ophthalmology Glaucoma are ranked highly in the field.

Newswise: New Study Reveals Reptiles’ Spontaneous Association Between Vision and Hearing
Released: 20-Jul-2023 1:10 PM EDT
New Study Reveals Reptiles’ Spontaneous Association Between Vision and Hearing
Queen Mary University of London

An international research team from Queen Mary University of London, UK and the Rovereto Civic Museum Foundation, Italy has made a groundbreaking discovery regarding reptiles and their ability to match visual and auditory information.

Newswise: Study Identifies How Diabetes Slows Healing in the Eye
Released: 19-Jul-2023 11:50 AM EDT
Study Identifies How Diabetes Slows Healing in the Eye
Cedars-Sinai

Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea.

Newswise: Light quality enhances contrast vision
Released: 19-Jul-2023 11:20 AM EDT
Light quality enhances contrast vision
Nagoya City University

Prof Sei-ichi Tsujimura of the Nagoya City University and Prof Su-Ling Yeh of National Taiwan University and Kagoshima University, have discovered that our visual acuity (contrast sensitivity) can be improved by using a light with a special spectrum that can selectively stimulate melanopsin cells in the retina.

Newswise: Report Highlights Public Health Impact of Serious Harms from Diagnostic Error in U.S.
Released: 17-Jul-2023 9:00 AM EDT
Report Highlights Public Health Impact of Serious Harms from Diagnostic Error in U.S.
Johns Hopkins Medicine

Improving diagnosis in health care is a moral, professional and public health imperative, according to the U.S. National Academy of Medicine.

Newswise: Humanity First USA and Loyola Medicine Partner to Expand Eye Care in Guatemala
Released: 14-Jul-2023 11:20 AM EDT
Humanity First USA and Loyola Medicine Partner to Expand Eye Care in Guatemala
Loyola Medicine

A new partnership between HF Healthcare Services, a wholly-owned subsidiary of Humanity First USA, and the distinguished Loyola Medicine, a member of Trinity Health, will develop a state-of-the-art Ophthalmology Department at Nasir Hospital in Guatemala, which will serve thousands of patients.

Released: 13-Jul-2023 4:45 PM EDT
Fear is in the eye of the beholder
University of Tokyo

Averting our eyes from things that scare us may be due to a specific cluster of neurons in a visual region of the brain, according to new research at the University of Tokyo.

   
Newswise: Gene that regulates immune activity in the retina identified
Released: 11-Jul-2023 11:25 AM EDT
Gene that regulates immune activity in the retina identified
UT Southwestern Medical Center

UT Southwestern Medical Center researchers have identified a gene called Lipe that appears to be pivotal to retinal health, with mutations spurring immune activation and retinal degeneration. This is important because the retina is responsible for detecting the light that is transformed into vision. The findings, published in Communications Biology, provide clues about the mechanisms behind a variety of disorders affecting the retina, including macular degeneration and diabetic retinopathy.

Newswise: Breaking Into Tears with Microrheology to Design Custom Eye Drops
6-Jul-2023 4:05 PM EDT
Breaking Into Tears with Microrheology to Design Custom Eye Drops
American Institute of Physics (AIP)

In Physics of Fluids, Vega et al. researched human tears at the micron level to reveal new ways of customizing artificial tears to address individual symptoms of dry eye disease. The detailed insights they gained about the composition and behavior of tears could also apply to the study of ocular pathogens as well as other biological fluids. The authors collected healthy human tears and tested 10 different formulations of artificial tears and applied microrheology methods using dynamic light scattering.

   
Released: 10-Jul-2023 3:05 PM EDT
New deep light imaging could improve disease diagnosis
University of St. Andrews

An international team of researchers, in collaboration with the University of St Andrews, have made a technology breakthrough for one of the most important forms of light imaging, optical coherence tomography (OCT), which could revolutionise applications in ophthalmology, dermatology, cardiology, and the early detection of cancer.

Newswise: The Medical Minute: Early detection key to protecting vision from glaucoma
Released: 6-Jul-2023 8:35 AM EDT
The Medical Minute: Early detection key to protecting vision from glaucoma
Penn State Health

Glaucoma can develop for years before you experience a symptom. A Penn State Health optometrist discusses early diagnosis and how testing can make all the difference for your vision.

Released: 5-Jul-2023 10:00 AM EDT
American Academy of Ophthalmology Establishes New Membership Group to Support Allied Health Professionals
American Academy of Ophthalmology (AAO)

The American Academy of Ophthalmology today announced that it has established a new membership group to support the professional interests of allied health professionals and will welcome in members of the Association of Technical Personnel in Ophthalmology.

Released: 5-Jul-2023 8:00 AM EDT
Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.

Newswise: Tips on Firework Safety from Doctors at the Midwest's Largest Burn Center
Released: 30-Jun-2023 1:15 PM EDT
Tips on Firework Safety from Doctors at the Midwest's Largest Burn Center
Loyola Medicine

While Loyola Medicine does not condone unsanctioned displays, if people participate, there are a number of safety precautions that can reduce or prevent injuries.

Released: 29-Jun-2023 6:05 PM EDT
Non-Invasive Approach Predicts Retinopathy of Prematurity Earlier
Ann and Robert H. Lurie Children's Hospital of Chicago

Research from Ann & Robert H. Lurie Children’s Hospital of Chicago promises to spare many premature infants from undergoing invasive eye exams to detect retinopathy of prematurity (ROP), the most common cause of preventable lifelong blindness in children in the U.S.

Released: 29-Jun-2023 5:05 PM EDT
Higher average temperature linked to serious vision impairment among older Americans
University of Toronto

American adults 65 years old and older living in warmer regions are more likely to have serious vision impairment than their peers living in cooler regions, according to a recent study published in the journal Ophthalmic Epidemiology.

Newswise: Computer Engineering Grads Design Assistive Glasses For People With Visual Impairments
Released: 29-Jun-2023 10:35 AM EDT
Computer Engineering Grads Design Assistive Glasses For People With Visual Impairments
California State University, Fullerton

To help people with visual impairments gain more independence, Cal State Fullerton computer engineering students developed assistive glasses, a hands-free wearable technology device. The glasses can help people with visual impairments detect and identify often-used objects — something a guide dog cannot always do.

   
Newswise: SLU Ophthalmologist: Fireworks, Eye Safety Tips You Need to Know
Released: 27-Jun-2023 1:05 PM EDT
SLU Ophthalmologist: Fireworks, Eye Safety Tips You Need to Know
Saint Louis University

Fourth of July celebrations and fireworks-related emergencies are here. Gabriela Espinoza, M.D., professor of ophthalmology at Saint Louis University School of Medicine, has eye safety tips you need to know.

Released: 19-Jun-2023 2:55 PM EDT
An oral probiotic can treat dry eye disease
American Society for Microbiology (ASM)

In a study by a research group at Baylor College of Medicine, oral administration of a commercially available probiotic bacterial strain was found to improve dry eye disease in an animal model.

Released: 16-Jun-2023 7:25 PM EDT
Significant correlation found between vitreous human biomarkers and Alzheimer’s disease
Boston Medical Center

New research from Boston Medical Center found a significant correlation between biomarkers in the vitreous humor of the eye and pathologically confirmed cases of Alzheimer’s disease (AD) and Chronic Traumatic Encephalopathy (CTE) in post-mortem brain and eye tissue.

Newswise: Intraocular corticosteroids best for treating complications of chronic inflammatory eye condition
8-Jun-2023 9:00 AM EDT
Intraocular corticosteroids best for treating complications of chronic inflammatory eye condition
NIH, National Eye Institute (NEI)

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).

Newswise: Making kid’s eye care more accessible
Released: 12-Jun-2023 1:55 PM EDT
Making kid’s eye care more accessible
Michigan Medicine - University of Michigan

Having the right care close to home is critical for many families.

Newswise: Seenu Hariprasad Named Chair of Ophthalmology and Visual Science at the University of Chicago
Released: 9-Jun-2023 10:05 AM EDT
Seenu Hariprasad Named Chair of Ophthalmology and Visual Science at the University of Chicago
University of Chicago Medical Center

Seenu M. Hariprasad, MD, the Shui-Chin Lee Professor of Ophthalmology, will be appointed Chair of the Department of Ophthalmology and Visual Science at the University of Chicago. He has been serving as Interim Chair since 2020.

Released: 7-Jun-2023 7:05 AM EDT
IIT Kanpur Pioneers Ground-Breaking Gene Therapy Technology for Hereditary Eye Diseases
Indian Institute of Technology Kanpur

IIT Kanpur has licensed a pioneering technology to Reliance Life Sciences Pvt. Ltd. that has the potential to revolutionize the field of gene therapy, especially for many genetic eye diseases, making it the first time that a gene therapy related technology has been developed and transferred from an academic institution to a company in India.

Newswise: Novel surgical technique may be more effective in treating common eyelid disorder
Released: 5-Jun-2023 11:15 AM EDT
Novel surgical technique may be more effective in treating common eyelid disorder
UT Southwestern Medical Center

A novel, minimally invasive surgical technique for correcting blepharoptosis – often called “droopy eyelid” – is more efficient and produces better results than the traditional method that uses sutures, according to a UT Southwestern Medical Center study. The findings, reported in the American Journal of Ophthalmology, may lead to a shift in how oculoplastic surgeons treat this common condition.

Released: 1-Jun-2023 4:55 PM EDT
Eye drops slow nearsightedness progression in kids, study finds
Ohio State University

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.

Released: 30-May-2023 4:05 PM EDT
28th Annual Glaucoma Foundation Think Tank Set for June 9/10
The Glaucoma Foundation

Established in 1995, the Glaucoma Foundation's Annual Think Tank has significantly increased the number of people around the world working in the field of glaucoma. All of the speakers at this 2-day will attend in person and the conference will be live-streamed on Zoom.

Released: 30-May-2023 8:05 AM EDT
Patricia A. D'Amore, PhD, MBA, FARVO, named 2023 - 2024 ARVO President
Association for Research in Vision and Ophthalmology (ARVO)

Last month at its 2023 Annual Meeting in New Orleans, La., the Association for Research in Vision and Ophthalmology (ARVO) welcomed Patricia A. D’Amore, PhD, MBA, FARVO, as its new president for April 2023 – May 2024. A member for more than 40 years, D’Amore is a Gold Fellow of ARVO (FARVO) ― a recognition of her individual accomplishments, leadership, and contributions to the Association.

Newswise:Video Embedded glaucoma-research-foundation-celebrates-45-years-of-scientific-innovation
VIDEO
Released: 25-May-2023 5:05 PM EDT
Glaucoma Research Foundation Celebrates 45 Years of Scientific Innovation
Glaucoma Research Foundation

Donors, patients, the board of directors, and volunteers joined together to mark an important milestone in Glaucoma Research Foundation’s history of innovation and collaboration. Ruth Williams, MD, Vice-Chair of the Board of Directors, was the keynote speaker.

Newswise: Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
Released: 25-May-2023 2:00 PM EDT
Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
Johns Hopkins Medicine

Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.

Newswise: AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Released: 24-May-2023 9:00 AM EDT
AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Johns Hopkins Medicine

Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

   
Released: 23-May-2023 11:45 AM EDT
Are we truly “inattentionally blind”? New study revisits “invisible gorilla” experiment for new insights
New York University

We are quite good at spotting unexpected objects while focused on another activity if they are moving fast, reveals a new study by a team of New York University researchers.

Released: 22-May-2023 3:30 PM EDT
Dr. Louis R. Pasquale Winner of the Glaucoma Foundation’s 2023 Robert Ritch Award
The Glaucoma Foundation

The Robert Ritch Award recognizes the contributions of individuals who have played a significant and unique role in promoting the medicine and science of glaucoma.

Newswise: Study: Blood Vessel Damage Could Be an Alzheimer’s Driver
Released: 19-May-2023 8:05 PM EDT
Study: Blood Vessel Damage Could Be an Alzheimer’s Driver
Cedars-Sinai

Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer’s disease, according to research from Cedars-Sinai investigators published in the peer-reviewed journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

Released: 18-May-2023 5:45 PM EDT
Visual processing before moving hands: insights into our visual sensory system
Tohoku University

Our hands do more than just hold objects. They also facilitate the processing of visual stimuli. When you move your hands, your brain first perceives and interprets sensory information, then it selects the appropriate motor plan before initiating and executing the desired movement.

Newswise: BGSU develops dimmable protective eyewear for U.S. Department of Defense
16-May-2023 10:10 AM EDT
BGSU develops dimmable protective eyewear for U.S. Department of Defense
Bowling Green State University

BGSU is partnering with public and private organizations to provide the U.S. Department of Defense with eyewear that electronically adjusts its tint from clear to dark in 0.1 seconds, a critical safety feature.

Newswise:Video Embedded nei-scientists-publish-recipe-for-making-blood-vessel-cells-from-patient-stem-cells
VIDEO
Released: 16-May-2023 9:30 AM EDT
NEI Scientists publish recipe for making blood vessel cells from patient stem cells
NIH, National Eye Institute (NEI)

Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.

Released: 15-May-2023 10:10 AM EDT
Mobius Therapeutics™ to Sponsor Educational Events on Compliance with USP <800>
Mobius Therapeutics, LLC

Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, will initiate a series of professional education sessions, focused on how end users of Mitosol® can achieve compliance with USP <800>, the soon to be implemented and enforced standards for control of hazardous drugs in healthcare facilities.

Newswise: New Museum of the Eye Exhibit Explores the Eye as a Cultural Symbol, From Ancient to Modern Times
Released: 10-May-2023 12:00 PM EDT
New Museum of the Eye Exhibit Explores the Eye as a Cultural Symbol, From Ancient to Modern Times
American Academy of Ophthalmology (AAO)

The Truhlsen-Marmor Museum of the Eye®, the world’s only free, public museum dedicated to the science of sight, today announced the opening of Decoding the Eye: Signs and Symbols, a new exhibit exploring how the eye appears as a symbol throughout time.

Released: 9-May-2023 1:25 PM EDT
New research sheds light on how human vision perceives scale
Aston University

The study, published on 8 May in the journal PLOS ONE, explored the computational mechanisms used by the human brain to perceive the size of objects in the world around us.

Newswise: UCI researchers discover new drugs with potential for treating world’s leading causes of blindness in age-related and inherited retinal diseases
Released: 8-May-2023 2:05 PM EDT
UCI researchers discover new drugs with potential for treating world’s leading causes of blindness in age-related and inherited retinal diseases
University of California, Irvine

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).



close
1.95656